These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34699141)

  • 21. A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek's diseases.
    Gergen L; Cook S; Ledesma B; Cress W; Higuchi D; Counts D; Cruz-Coy J; Crouch C; Davis P; Tarpey I; Morsey M
    Avian Pathol; 2019 Feb; 48(1):45-56. PubMed ID: 30404540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular-based monitoring of live vaccines in dust samples from experimental and commercial chicken flocks and its potential use as a screening test.
    Assen AM; Yegoraw AA; Walkden-Brown SW; Gerber PF
    Res Vet Sci; 2022 Mar; 143():50-57. PubMed ID: 34973539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyvalent recombinant Marek's disease virus vaccine against poultry diseases.
    Hirai K; Sakaguchi M
    Curr Top Microbiol Immunol; 2001; 255():261-87. PubMed ID: 11217427
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative Protective Efficacies of Novel Avian Paramyxovirus-Vectored Vaccines against Virulent Infectious Bronchitis Virus in Chickens.
    Shirvani E; Samal SK
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32605292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of HVT-IBD vector vaccine compared to attenuated live vaccine using in-ovo vaccination against a Korean very virulent IBDV in commercial broiler chickens.
    Roh JH; Kang M; Wei B; Yoon RH; Seo HS; Bahng JY; Kwon JT; Cha SY; Jang HK
    Poult Sci; 2016 May; 95(5):1020-4. PubMed ID: 26944964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of turkey herpesvirus-infectious bursal disease vector vaccine with Marek's disease rispens vaccine injected into day-old pullets.
    Lemiere S; Wong SY; Saint-Gerand AL; Goutebroze S; Le Gros FX
    Avian Dis; 2011 Mar; 55(1):113-8. PubMed ID: 21500646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
    Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
    PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a novel in ovo-attenuated live vaccine and recombinant vaccine against a very virulent infectious bursal disease virus in chickens.
    Okura T; Otomo H; Suzuki S; Ono Y; Taneno A; Oishi E
    J Vet Med Sci; 2021 Oct; 83(11):1686-1693. PubMed ID: 34526420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens.
    Ferreira HL; Reilley AM; Goldenberg D; Ortiz IRA; Gallardo RA; Suarez DL
    Vaccine; 2020 Jul; 38(34):5507-5515. PubMed ID: 32591288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the efficacy of a live fowlpox-vectored infectious laryngotracheitis/avian encephalomyelitis vaccine against ILT viral challenge.
    Davison S; Gingerich EN; Casavant S; Eckroade RJ
    Avian Dis; 2006 Mar; 50(1):50-4. PubMed ID: 16617981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Status of Poultry Recombinant Virus Vector Vaccine Development.
    Wang H; Tian J; Zhao J; Zhao Y; Yang H; Zhang G
    Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against infectious laryngotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines.
    Johnson DI; Vagnozzi A; Dorea F; Riblet SM; Mundt A; Zavala G; García M
    Avian Dis; 2010 Dec; 54(4):1251-9. PubMed ID: 21313847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against Marek's disease and infectious bursal disease. II. Titration and in vivo efficacy of the coinfection-derived bivalent live vaccine for turkey herpesvirus and infectious bursal disease virus.
    Chang JD; Eidson CS; Kleven SH; Fletcher OJ
    Poult Sci; 1984 Sep; 63(9):1752-8. PubMed ID: 6091083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
    Wei X; Shao Y; Han Z; Sun J; Liu S
    Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant turkey herpesvirus-infectious bursal disease vector vaccine and oil-adjuvanted inactivated Newcastle disease vaccine administration: consequences for vaccine intake and protection.
    Lemiere S; Fernández R; Pritchard N; Cruz-Coy J; Rojo F; Wong SY; Saint-Gerand AL; Gauthier JC; Perozo F
    Avian Dis; 2011 Dec; 55(4):642-9. PubMed ID: 22312985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous construction strategy using two types of fluorescent markers for HVT vector vaccine against infectious bursal disease and H9N2 avian influenza virus by NHEJ-CRISPR/Cas9.
    Zhang JF; Shang K; Kim SW; Park JY; Wei B; Jang HK; Kang M; Cha SY
    Front Vet Sci; 2024; 11():1385958. PubMed ID: 38812565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of a recombinant avian avulavirus serotype 10 vectored vaccine by the addition of untranslated regions.
    Tsunekuni R; Tanikawa T; Nakaya T; Saito T
    Vaccine; 2020 Jan; 38(4):822-829. PubMed ID: 31718900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.